Jonny Harcourt
YOU?
Author Swipe
View article: The effects of coronavirus disease 2019 diagnosis and national lockdown on hearing loss, tinnitus, vertigo and migraine: the outcome of a prospective cohort study
The effects of coronavirus disease 2019 diagnosis and national lockdown on hearing loss, tinnitus, vertigo and migraine: the outcome of a prospective cohort study Open
Objectives To identify changes in hearing loss, tinnitus, vertigo, and migraine in individuals with Ménière’s disease diagnosed with coronavirus disease 2019 and during the UK national lockdown. Method Patients were questioned regarding co…
View article: Development of a National Ménière’s Disease Registry: A Feasibility Study
Development of a National Ménière’s Disease Registry: A Feasibility Study Open
Background: Ménière’s disease is a disabling condition causing vertigo and hearing loss yet remains incompletely understood. Registry studies have the potential to answer important questions about phenotypes and natural history of clinical…
View article: Development of a national Ménière’s disease registry: a feasibility study
Development of a national Ménière’s disease registry: a feasibility study Open
Objectives To examine the methods and infrastructure necessary to establish a national Ménière’s disease registry Design Observational study. Four NHS Trusts and four independent hospitals or clinics, within three distinct urban and rural …
View article: Tablet and web-based audiometry to screen for hearing loss in adults with cystic fibrosis
Tablet and web-based audiometry to screen for hearing loss in adults with cystic fibrosis Open
Introduction Individuals with chronic lung disease (eg, cystic fibrosis (CF)) often receive antimicrobial therapy including aminoglycosides resulting in ototoxicity. Extended high-frequency audiometry has increased sensitivity for ototoxic…
View article: Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Menière's Disease
Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Menière's Disease Open
Objectives: To determine whether long term (>48 months) symptomatic vertigo control is sustained in patients with Menière's disease from a previous comparative trial of intratympanic methylprednisolone versus gentamicin, and if the two tre…
View article: REPLY TO ADRION ET AL. ON PATEL ET AL. Letter to the Editor, British Medical Journal
REPLY TO ADRION ET AL. ON PATEL ET AL. Letter to the Editor, British Medical Journal Open
We apologise for not having noticed earlier Adrion and colleagues’ comments on our study comparing the effectiveness of intratympanic Methylprednisolone to Gentamicin in refractory Ménière’s disease [1], covered by the BMJ [2]. Contrary to…
View article: Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial
Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial Open
Ménière's Society and National Institute for Health Research Imperial Biomedical Research Centre.
View article: A study of the otological outcomes of otitis media with effusion in children with primary ciliary dyskinesia
A study of the otological outcomes of otitis media with effusion in children with primary ciliary dyskinesia Open
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.